Literature DB >> 13066725

Some observations on the cholinesterases of the central nervous system after the administration of organo-phosphorus compounds.

A N DAVISON.   

Abstract

Entities:  

Keywords:  CENTRAL NERVOUS SYSTEM/metabolism; CHOLINESTERASE; PHOSPHORUS/toxicity

Mesh:

Substances:

Year:  1953        PMID: 13066725      PMCID: PMC1509337          DOI: 10.1111/j.1476-5381.1953.tb00781.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  6 in total

1.  Pseudocholinesterase of brain.

Authors:  B MENDEL; D K MYERS
Journal:  Nature       Date:  1952-11-29       Impact factor: 49.962

2.  The distribution of cholinesterase types in mammalian tissues.

Authors:  M G Ord; R H Thompson
Journal:  Biochem J       Date:  1950-03       Impact factor: 3.857

3.  The inhibitory action of tri-ortho-cresyl phosphate on cholinesterases.

Authors:  C J EARL; R H S THOMPSON
Journal:  Br J Pharmacol Chemother       Date:  1952-06

4.  The regeneration of red cell and plasma cholinesterases in humans and dogs following poisoning by bis (isopropylamino) fluorophosphine oxide.

Authors:  S CALLAWAY; D R DAVIES; J E RISLEY
Journal:  Biochem J       Date:  1952-03       Impact factor: 3.857

5.  Some properties of specific cholinesterase with particular reference to the mechanism of inhibition by diethyl p-nitrophenyl thiophosphate (E 605) and analogues.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1950-04       Impact factor: 3.857

6.  Studies on cholinesterase: 3. Specific tests for true cholinesterase and pseudo-cholinesterase.

Authors:  B Mendel; D B Mundell; H Rudney
Journal:  Biochem J       Date:  1943-10       Impact factor: 3.857

  6 in total
  10 in total

1.  The results of intoxication with orthocresyl phosphate absorbed from contaminated cooking oil, as seen in 4,029 patients in Morocco.

Authors:  P R TRAVERS
Journal:  Proc R Soc Med       Date:  1962-01

2.  Localization of cholinesterases in the chicken nervous system and the problem of the selective neurotoxicity of organophosphorus compounds.

Authors:  J B CAVANAGH; P HOLLAND
Journal:  Br J Pharmacol Chemother       Date:  1961-06

3.  Tri-O-tolyl phosphate neurotoxicity: lack of evidence for autoimmunologic involvement.

Authors:  P G Watanabe; R P Sharma
Journal:  Arch Environ Contam Toxicol       Date:  1977       Impact factor: 2.804

Review 4.  Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity.

Authors:  C D Carrington
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

5.  Neurotoxic syndrome produced in chickens by a cyclic phosphate metabolite of tri-o-cresyl phosphate--a clinical and pathological study.

Authors:  R L BARON; D R BENNETT; J E CASIDA
Journal:  Br J Pharmacol Chemother       Date:  1962-06

Review 6.  Organophosphorus esters causing delayed neurotoxic effects: mechanism of action and structure activity studies.

Authors:  M K Johnson
Journal:  Arch Toxicol       Date:  1975-12-18       Impact factor: 5.153

7.  Correlation of neuropathy target esterase activity with specific tritiated di-isopropyl phosphorofluoridate-labelled proteins.

Authors:  T C Thomas; Y Ishikawa; M G McNamee; B W Wilson
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

8.  Rapid aging of neurotoxic esterase after inhibition by di-isopropyl phosphorofluoridate.

Authors:  B Clothier; M K Johnson
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

9.  Enzyme studies with human and hen autopsy tissue suggest omethoate does not cause delayed neuropathy in man.

Authors:  M Lotti; S D Ferrara; S Caroldi; F Sinigaglia
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

10.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.